$14.53
In chiusura: Oct 17, 4:01 PM EDT
$14.53
0.000.00%
Pre-mercato: Oct 17, 4:01 PM EDT
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Tactile Systems Tech. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Tactile Systems Tech.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Tactile Systems Technology Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno agosto 12, 2025, Louise Sheri Dodd, l'azienda CHIEF EXECUTIVE OFFICER sold 7.76K condivisioni per $12.36 ciascuna.
Statistiche sulla proprietà per Tactile Systems Technology Inc
Numero di azioni emesse
22.292M
Azioni possedute dagli insider
1.634M
Percentuale posseduta dagli Insider
7.33%
Azioni possedute dagli investitori istituzionali
9.622M
Percentuale posseduta dagli investitori istituzionali
43.2%
Aug 12, 2025 | CHIEF EXECUTIVE OFFICER | -7.76K | $12.36 | -$95.91K | SELL | -4.28% | 173.48K | Aug 08 | ||
May 14, 2025 | CHIEF FINANCIAL OFFICER | -2.92K | $9.94 | -$29.04K | SELL | -2.86% | 99.11K | May 12 | ||
May 12, 2025 | CHIEF EXECUTIVE OFFICER | -3.15K | $9.83 | -$30.95K | SELL | -1.71% | 181.24K | May 08 | ||
May 09, 2025 | DIRECTOR | 12.78K | $9.67 | -$31.91K | GRANT | 35.75% | 48.52K | May 07 - May 08 | ||
Feb 27, 2025 | CHIEF FINANCIAL OFFICER | -2.07K | $14.51 | -$29.98K | SELL | -1.98% | 102.03K | Feb 25 | ||
Feb 27, 2025 | SR. VP MKTG & CLINICAL AFFAIRS | -6.47K | $14.40 | -$93.16K | SELL | -7.70% | 77.54K | Feb 25 | ||
Feb 27, 2025 | DIRECTOR | -28.34K | $14.18 | -$401.85K | SELL | -11.66% | 214.60K | Feb 25 | ||
Feb 24, 2025 | DIRECTOR | 4.92K | $14.55 | -$159.15K | GRANT | 2.06% | 242.94K | Feb 20 - Feb 24 | ||
Feb 24, 2025 | SR. VP MKTG & CLINICAL AFFAIRS | 19.24K | $14.65 | -$70.75K | GRANT | 29.70% | 84.01K | Feb 20 - Feb 24 | ||
Feb 24, 2025 | CHIEF FINANCIAL OFFICER | 42.80K | $14.70 | -$55.54K | GRANT | 69.83% | 104.10K | Feb 20 - Feb 24 | ||
Aug 14, 2024 | SENIOR VP, SALES | -1.55K | $13.07 | -$20.26K | SELL | -3.84% | 38.76K | Aug 12 | ||
May 20, 2024 | CHIEF FINANCIAL OFFICER | -3.04K | $13.68 | -$41.59K | SELL | -4.73% | 61.30K | May 16 | ||
May 10, 2024 | DIRECTOR | 7.97K | $14.06 | -$35.15K | GRANT | 28.69% | 35.74K | May 08 | ||
May 08, 2024 | SR. VP MKTG & CLINICAL AFFAIRS | -815.00 | $14.37 | -$11.71K | SELL | -1.29% | 62.57K | May 06 | ||
Feb 29, 2024 | SR. VP MKTG & CLINICAL AFFAIRS | -1.33K | $15.52 | -$20.71K | SELL | -2.06% | 63.39K | Feb 27 - Feb 29 | ||
Feb 29, 2024 | PRESIDENT AND CEO | -6.08K | $15.52 | -$94.44K | SELL | -2.49% | 238.03K | Feb 27 - Feb 29 | ||
Feb 27, 2024 | PRESIDENT AND CEO | 46.41K | $15.37 | -$178.50K | GRANT | 23.48% | 244.11K | Feb 23 - Feb 26 | ||
Feb 27, 2024 | SR. VP MKTG & CLINICAL AFFAIRS | 7.50K | $15.32 | -$65.33K | GRANT | 13.39% | 63.51K | Feb 23 - Feb 26 | ||
Aug 09, 2023 | PRESIDENT AND CEO | -1.06K | $20.53 | -$21.81K | SELL | -0.84% | 125.65K | Aug 07 | ||
May 16, 2023 | DIRECTOR | -4.40K | $21.86 | -$96.18K | SELL | -13.68% | 27.77K | May 12 | ||
May 10, 2023 | SR. VP MKTG & CLINICAL AFFAIRS | -786.00 | $18.65 | -$14.66K | SELL | -2.10% | 36.56K | May 08 | ||
May 10, 2023 | SENIOR VP, SALES | -550.00 | $18.55 | -$10.20K | SELL | -1.83% | 29.50K | May 08 | ||
Mar 03, 2023 | CHIEF FINANCIAL OFFICER | -1.39K | $14.10 | -$19.61K | SELL | -2.77% | 48.76K | Mar 01 | ||
Feb 28, 2023 | PRESIDENT AND CEO | -605.00 | $15.20 | -$107.72K | SELL | -0.48% | 126.72K | Feb 25 - Feb 28 | ||
Feb 28, 2023 | CHIEF FINANCIAL OFFICER | -1.75K | $15.32 | -$62.06K | SELL | -3.37% | 50.15K | Feb 25 - Feb 28 | ||
Feb 28, 2023 | SR. VP MKTG & CLINICAL AFFAIRS | -1.33K | $15.34 | -$35.24K | SELL | -3.45% | 37.35K | Feb 25 - Feb 28 | ||
Feb 28, 2023 | SENIOR VP, SALES | -878.00 | $15.29 | -$22.52K | SELL | -2.84% | 30.05K | Feb 25 - Feb 28 | ||
Aug 10, 2022 | PRESIDENT AND CEO | -1.02K | $9.18 | -$9.36K | SELL | -1.35% | 74.71K | Aug 08 | ||
Aug 08, 2022 | DIRECTOR | 4.90K | $9.15 | $44.84K | BUY | 25.08% | 24.44K | Aug 04 | ||
May 23, 2022 | DIRECTOR | -1.10K | $10.12 | -$11.13K | SELL | -5.33% | 19.54K | May 19 | ||
May 10, 2022 | SR. VP MKTG & CLINICAL AFFAIRS | -999.00 | $13.04 | -$13.02K | SELL | -4.35% | 21.96K | May 06 | ||
May 10, 2022 | SENIOR VP, SALES | -600.00 | $13.03 | -$7.82K | SELL | -3.17% | 18.30K | May 06 | ||
Mar 09, 2022 | CHIEF FINANCIAL OFFICER | -176.00 | $20.64 | -$3.63K | SELL | -0.34% | 51.90K | Mar 07 | ||
Mar 03, 2022 | CHIEF FINANCIAL OFFICER | -1.63K | $20.33 | -$33.18K | SELL | -3.04% | 52.08K | Mar 01 | ||
Feb 28, 2022 | PRESIDENT AND CEO | 53.06K | $19.78 | -$17.35K | GRANT | 234.08% | 75.73K | Feb 24 - Feb 28 | ||
Feb 28, 2022 | CHIEF FINANCIAL OFFICER | 28.50K | $19.84 | -$12.38K | GRANT | 113.08% | 53.71K | Feb 24 - Feb 28 | ||
Aug 09, 2021 | PRESIDENT AND CEO | -1.06K | $43.11 | -$45.83K | SELL | -4.48% | 22.67K | Aug 06 | ||
Jul 07, 2021 | PRESIDENT AND CEO | -2.96K | $49.75 | -$147.32K | SELL | -11.09% | 23.73K | Jul 07 | ||
Jun 28, 2021 | DIRECTOR | 1.00K | $37.31 | -$219.60K | SELL-OPTIONS | 13.27% | 8.53K | Jun 24 | ||
May 17, 2021 | DIRECTOR | -800.00 | $52.08 | -$41.66K | SELL | -13.69% | 5.04K | May 13 | ||
Mar 09, 2021 | CHIEF FINANCIAL OFFICER | -174.00 | $47.33 | -$8.23K | SELL | -0.67% | 25.69K | Mar 05 | ||
Mar 09, 2021 | SVP, SALES | -196.00 | $47.15 | -$9.24K | SELL | -0.52% | 37.57K | Mar 05 | ||
Mar 02, 2021 | CHIEF FINANCIAL OFFICER | 2.91K | $52.08 | -$117.45K | GRANT | 12.69% | 25.86K | Feb 25 - Feb 28 | ||
Mar 02, 2021 | SVP, SALES | -1.14K | $53.12 | -$180.75K | SELL | -2.94% | 37.76K | Feb 25 - Feb 28 | ||
Jan 06, 2021 | DIRECTOR | 0.00 | $27.57 | -$52.70K | SELL-OPTIONS | 0.00% | 5.84K | Jan 04 | ||
Nov 04, 2020 | — | 0.00 | $23.75 | -$41.25K | OPTION EXERCISE | 0.00% | 5.84K | Nov 02 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.